OSTX – os therapies incorporated (US:NASDAQ)
Stock Stats
News
OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates
OS Therapies Announces Positive Efficacy and Safety Data for Ovarian Cancer Therapeutic Candidate Developed Based on Tunable Antibody Drug Conjugate (tADC) Platform Using Proprietary Silicone Linker Platform in Preclinical Models
OS Therapies Inc (NYSE: OSTX) was upgraded by analysts at EF Hutton Acquisition Co. I to a "strong-buy" rating.
OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference
OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose
Form SC 13G OS Therapies Inc Filed by: SATTERFIELD THOMAS A JR
Form 8-K OS Therapies Inc For: Aug 22
Form 8-K OS Therapies Inc For: Aug 15
Form 10-Q OS Therapies Inc For: Jun 30
Form 4 OS Therapies Inc For: Aug 02 Filed by: Search Theodore F.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.